These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 34916973)
21. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking. Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487 [TBL] [Abstract][Full Text] [Related]
22. Niacin inhibits the synthesis of milk fat in BMECs through the GPR109A-mediated downstream signalling pathway. Wang J; Cao Y; Fu S; Li W; Ge Y; Cheng J; Liu J Life Sci; 2020 Nov; 260():118415. PubMed ID: 32918974 [TBL] [Abstract][Full Text] [Related]
23. Future of GPR109A agonists in the treatment of dyslipidaemia. Wanders D; Judd RL Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500 [TBL] [Abstract][Full Text] [Related]
24. Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A. Giri B; Belanger K; Seamon M; Bradley E; Purohit S; Chong R; Morgan JC; Baban B; Wakade C Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540057 [TBL] [Abstract][Full Text] [Related]
25. Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives. Lin SH; Liu CM; Chang SS; Hwu HG; Liu SK; Hwang TJ; Hsieh MH; Guo SC; Chen WJ Schizophr Bull; 2007 Jan; 33(1):174-82. PubMed ID: 16936284 [TBL] [Abstract][Full Text] [Related]
34. A novel treatment target for Parkinson's disease. Wakade C; Chong R J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298 [TBL] [Abstract][Full Text] [Related]
35. The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism. Geisler CE; Miller KE; Ghimire S; Renquist BJ Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924461 [TBL] [Abstract][Full Text] [Related]
36. Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosis. Gan R; Wei Y; Wu G; Zeng J; Hu Y; Xu L; Tang X; Liu X; Liu H; Chen T; Wang J; Zhang T Gen Psychiatr; 2022; 35(2):e100748. PubMed ID: 35572776 [TBL] [Abstract][Full Text] [Related]
37. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566 [TBL] [Abstract][Full Text] [Related]
38. Seeing red: flushing out instigators of niacin-associated skin toxicity. Dunbar RL; Gelfand JM J Clin Invest; 2010 Aug; 120(8):2651-5. PubMed ID: 20664168 [TBL] [Abstract][Full Text] [Related]
39. Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Li X; Millar JS; Brownell N; Briand F; Rader DJ Biochem Pharmacol; 2010 Nov; 80(9):1450-7. PubMed ID: 20655299 [TBL] [Abstract][Full Text] [Related]
40. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? Kamanna VS; Kashyap ML Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]